Template:Anxiolytics: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import |
en>Ahecht m Reduce WP:PEIS (transcluded on Alcohol (drug)) (via WP:JWB) |
||
| Line 1: | Line 1: | ||
{{ | {{#invoke:navbox|navbox | ||
| name = Anxiolytics | | name = Anxiolytics | ||
| title = [[Anxiolytic]]s ([[ATC code N05#N05B|N05B]]) | | title = [[Anxiolytic]]s ([[ATC code N05#N05B|N05B]]) | ||
| Line 9: | Line 9: | ||
| list1 = | | list1 = | ||
* [[Buspirone]] | * [[Buspirone]] | ||
* [[Gepirone]] | * [[Gepirone]] | ||
* [[Tandospirone]] | * [[Tandospirone]] | ||
| Line 37: | Line 37: | ||
* [[Prazepam]]; ''Others:'' [[Alpidem]]<sup>‡</sup> | * [[Prazepam]]; ''Others:'' [[Alpidem]]<sup>‡</sup> | ||
* [[Barbiturate]]s (e.g., [[phenobarbital]]) | * [[Barbiturate]]s (e.g., [[phenobarbital]]) | ||
* [[Carbamate]]s (e.g., [[meprobamate]]) | |||
* [[Carisoprodol]] | * [[Carisoprodol]] | ||
* [[Chlormezanone]]<sup>‡</sup> | * [[Chlormezanone]]<sup>‡</sup> | ||
* [[Alcohol (drug)|Ethanol (alcohol)]] | * [[Alcohol (drug)|Ethanol (alcohol)]] | ||
* [[Etifoxine]] | * [[Etifoxine]] | ||
| group3 = [[Gabapentinoid]]s<br /> | | group3 = [[Hypnotic]]s | ||
| | | list3 = | ||
* [[Zopiclone]] | |||
| group4 = [[Gabapentinoid]]s<br /><span style="font-size:85%;">([[Voltage-dependent calcium channel#.CE.B12.CE.B4_Subunit|{{abbr|α<sub>2</sub>δ|alpha2delta subunit}} {{abbr|VDCC|voltage-dependent calcium channel}}]] [[channel blocker|blocker]]s)</span> | |||
| list4 = | |||
* [[Gabapentin]] | * [[Gabapentin]] | ||
* [[Gabapentin enacarbil]] | * [[Gabapentin enacarbil]] | ||
| Line 54: | Line 55: | ||
* [[Pregabalin]] | * [[Pregabalin]] | ||
| | | group5 = [[Antidepressant]]s | ||
| | | list5 = | ||
* {{abbrlink|SSRIs|Selective serotonin reuptake inhibitors}} (e.g., [[escitalopram]]) | * {{abbrlink|SSRIs|Selective serotonin reuptake inhibitors}} (e.g., [[escitalopram]]) | ||
* {{abbrlink|SNRIs|Serotonin-norepinephrine reuptake inhibitors}} (e.g., [[duloxetine]]) | * {{abbrlink|SNRIs|Serotonin-norepinephrine reuptake inhibitors}} (e.g., [[duloxetine]]) | ||
| Line 67: | Line 68: | ||
* [[Vortioxetine]] | * [[Vortioxetine]] | ||
| | | group6 = [[Antipsychotic]]s | ||
| | | list6 = | ||
* [[Quetiapine]] | |||
* [[Flupentixol]] | |||
| group7 = [[Sympatholytic]]s<br /><span style="font-size:85%;">([[Antiadrenergic]]s)</span> | |||
| list7 = | |||
* [[Alpha-1 blocker]]s (e.g., [[prazosin]]) | * [[Alpha-1 blocker]]s (e.g., [[prazosin]]) | ||
* [[Alpha-2 agonist]]s (e.g., [[clonidine]], [[dexmedetomidine]], [[guanfacine]]) | * [[Alpha-2 agonist]]s (e.g., [[clonidine]], [[dexmedetomidine]], [[guanfacine]]) | ||
* [[Beta blocker]]s (e.g., [[propranolol]]) | * [[Beta blocker]]s (e.g., [[propranolol]]) | ||
| | | group8 = Others | ||
| | | list8 = | ||
* [[Benzoctamine]] | * [[Benzoctamine]] | ||
* [[Cycloserine]] | * [[Cycloserine]] | ||
* [[Fabomotizole]] | * [[Fabomotizole]] | ||
* [[Hydroxyzine]] | * [[Hydroxyzine]] | ||
* [[Lorpiprazole]] | * [[Lorpiprazole]] | ||
* [[Mebicar]] | * [[Mebicar]] | ||
| Line 96: | Line 101: | ||
* [[Validolum]] | * [[Validolum]] | ||
| | | list9 = {{PharmNavFootnote}} | ||
}} | }}<noinclude> | ||
<noinclude> | |||
{{collapsible option}} | {{collapsible option}} | ||
[[Category:Drug_templates by ATC]] | [[Category:Drug_templates by ATC]] | ||
</noinclude> | </noinclude> | ||
